Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-07-30

FDA Approved: DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE — Supplemental Application (Analog Pharma)

View source ↗

Summary

FDA approved a supplemental application for doxylamine succinate and pyridoxine hydrochloride (Analog Pharma), updating the labeling under NDA 021876.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE (doxylamine succinate and pyridoxine hydrochloride)

Snippet

SUPPL AP for DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE (DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE)